PDF(871 KB)
Inhibition of ferroptosis by geniposide via activation of the SIRT3 signaling pathway to alleviate inflammatory injury in endothelial cells
Wen-Ting SUN, Miao-Miao ZHAO, Zhao-Ling SHI
Chinese Journal of Contemporary Pediatrics ›› 2026, Vol. 28 ›› Issue (4) : 486-492.
PDF(871 KB)
PDF(871 KB)
Inhibition of ferroptosis by geniposide via activation of the SIRT3 signaling pathway to alleviate inflammatory injury in endothelial cells
Objective To study the effect and mechanism of geniposide (GE) on lipopolysaccharide (LPS)-induced inflammatory injury in human coronary artery endothelial cells (HCAECs). Methods HCAECs were randomly assigned to four groups: control (no treatment); model (LPS 20 ng/mL for 24 hours); GE (GE 30 μg/mL pretreatment for 12 hours, followed by LPS 20 ng/mL for 24 hours); and SIRT3 inhibitor (GE 40 μg/mL plus the SIRT3-specific inhibitor 3-TYP pretreatment for 12 hours, followed by LPS 20 ng/mL for 24 hours). Cell viability was assessed by CCK-8 assay. Lactate dehydrogenase (LDH) activity in culture medium and intracellular malondialdehyde (MDA), glutathione (GSH), and ferrous ion (Fe2+) levels were measured using commercial kits. Reactive oxygen species (ROS) were evaluated by DCFH-DA fluorescent probe method. Western blotting detected the protein expression of silent information regulator 3 (SIRT3), glutathione peroxidase 4 (GPX4), solute carrier family 7 member 11 (SLC7A11), and transferrin receptor 1 (TfR1). SIRT3 expression was examined by immunofluorescence staining. Results Compared with the control group, the model group showed decreased cell viability, GSH content, SIRT3 immunofluorescence intensity, and GPX4, SLC7A11, and SIRT3 protein expression (P<0.05), with increased LDH activity, TfR1 protein expression, and MDA, Fe2+, and ROS levels (P<0.05). Compared with the model group, the GE group exhibited increased cell viability, GSH content, SIRT3 immunofluorescence intensity, and GPX4, SLC7A11, and SIRT3 protein expression (P<0.05), and decreased LDH activity, TfR1 protein expression, and MDA, Fe2+, and ROS levels (P<0.05). Compared with the GE group, the SIRT3 inhibitor group showed reduced cell viability, GSH content, SIRT3 immunofluorescence intensity, and GPX4, SLC7A11, and SIRT3 protein expression (P<0.05), along with elevated LDH activity, TfR1 protein expression, and MDA, Fe2+, and ROS levels (P<0.05). Conclusions Geniposide alleviates LPS-induced inflammatory injury in HCAECs, and the mechanism may involve inhibition of ferroptosis and activation of SIRT3 signaling.
Geniposide / Silent information regulator 3 / Ferroptosis / Lipopolysaccharide / Human coronary artery endothelial cell
| [1] |
焦富勇, 穆志龙, 杜忠东, 等. 儿童不完全性川崎病的诊治[J]. 中国当代儿科杂志, 2023, 25(3): 238-243. PMCID: PMC10032064. DOI: 10.7499/j.issn.1008-8830.2209127 .
|
| [2] |
中华医学会儿科学分会心血管学组, 中华医学会儿科学分会风湿学组, 中华医学会儿科学分会免疫学组, 等. 川崎病诊断和急性期治疗专家共识[J]. 中华儿科杂志, 2022, 60(1): 6-13. DOI: 10.3760/cma.j.cn112140-20211018-00879 .
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
刘彩霞, 邓常清. 中药及复方改善血管内皮细胞氧化应激损伤的研究进展[J]. 湖南中医药大学学报, 2021, 41(1): 151-158. DOI: 10.3969/j.issn.1674-070X.2021.01.029 .
|
| [9] |
张嘉豪, 呼田, 周雪薇, 等. 栀子药理作用及临床应用研究进展[J]. 辽宁中医药大学学报, 2024, 26(5): 93-98. DOI: 10.13194/j.issn.1673-842x.2024.05.016 .
|
| [10] |
蔡智慧, 尹丽, 常全忠. 栀子苷预处理对 H9C2心肌细胞缺氧/复氧损伤的影响及机制研究[J]. 天津中医药, 2016, 33(2): 111-113. DOI: 10.11656/j.issn.1672-1519.2016.02.13 .
|
| [11] |
|
| [12] |
|
| [13] |
王梦艳, 刘杰, 黄聿, 等. 非血管性疾病与动脉粥样硬化: 内皮炎症和氧化应激的关键作用[J]. 中国动脉硬化杂志, 2023, 31(4): 287-296. DOI: 10.20039/j.cnki.1007-3949.2023.04.002 .
|
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
王莉, 黄杰安, 梁俐, 等. 铁死亡的作用机制及其在肿瘤耐药中的研究进展[J]. 中国药物经济学, 2021, 16(6): 125-128. DOI: 10.12010/j.issn.1673-5846.2021.06.031 .
|
| [22] |
杨岚婷, 徐涛, 杨福情, 等. 转铁蛋白受体对铁过载所致大鼠心肌细胞铁死亡的作用及其机制[J]. 解放军医学杂志, 2022, 47(8): 781-788. DOI: 10.11855/j.issn.0577-7402.2022.08.0781 .
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
杨春昆, 潘清泉, 吉奎, 等. 川芎嗪对心血管的保护机制综述[J]. 中国中药杂志, 2023, 48(6): 1446-1454. DOI: 10.19540/j.cnki.cjcmm.20221012.402 .
|
| [27] |
|
所有作者均声明不存在利益冲突。